Content in this topic
Any revised version of the Moderna COVID-19 vaccine will likely include a smaller dose, reducing side effects and increasing the supply of shots.
A mass vaccination experiment in Brazil suggests that even a moderately effective vaccine can have a dramatic effect if enough people get the shot.
An inhaled nanobody treatment for COVID-19 has shown promise in animal tests and could be a more affordable alternative to monoclonal antibody drugs.
Singapore has provisionally authorized a COVID-19 breath test that measures VOCs to deliver accurate results in just one minute.
An inhaled CRISPR treatment can be easily tweaked to attack a variety of viruses, from the one that causes the flu to the coronavirus behind COVID-19.
Australian researchers have found an immune response measurement they believe can predict protection against COVID-19.
Ohio’s vaccine lottery, which will give five vaccinated residents $1 million each, appears to have sparked the desired increase in new vaccinations.
Human challenge trials are risky, but they could help us avoid another prolonged pandemic.
If protection against a potentially deadly virus isn’t enough, there are these added incentives to get the COVID-19 vaccine.